H.R.2592 - Safe and Effective Drug Development Act of 2007
To amend the Federal Food, Drug, and Cosmetic Act to provide for one or more Critical Path Public-Private Partnerships to implement the Critical Path Initiative of the Food and Drug Administration, and for other purposes. view all titles (2)
All Bill Titles
- Official: To amend the Federal Food, Drug, and Cosmetic Act to provide for one or more Critical Path Public-Private Partnerships to implement the Critical Path Initiative of the Food and Drug Administration, and for other purposes. as introduced.
- Short: Safe and Effective Drug Development Act of 2007 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Bill's Views
- Today: 1
- Past Seven Days: 6
- All-Time: 1,096
|
|
|
|
|
|
|
|
Official Summary
6/6/2007--Introduced.Safe and Effective Drug Development Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to enter into Critical Path Public-Private Partnerships with eligOfficial Summary
6/6/2007--Introduced.Safe and Effective Drug Development Act of 2007 - Amends the Federal Food, Drug, and Cosmetic Act to require the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to enter into Critical Path Public-Private Partnerships with eligible entities to implement the Critical Path Initiative of the Food and Drug Administration (FDA) by developing research, education, and outreach projects to foster medical product innovation, accelerate medical product development, and enhance medical product safety. Prohibits such an entity from accepting any funding for the technical programs of a Critical Path Public-Private Partnership from any individual or organization that manufactures, distributes, or sells any FDA-regulated product. Establishes an exception for accepting funds from a consortium of companies whose products are FDA-regulated if the Secretary determines that such acceptance would not result in any conflict of interest and issues a waiver.
...Read the Rest
Recent News Coverage
Hmmmm, no news coverage found for this bill at this time. This means that this this bill has not yet been mentioned on a publicly-searchable news website by either its official number (for example, "H.R. 3200") or title (for example, "America's Affordable Health Choices Act of 2009"). As soon as that changes, our daily automated search across the Web will catch it and include it here. If this bill is of interest to you, you can write a letter to the editor referring to this bill by name, and if your letter is published on the Web, a link back your letter will appear here within about one day. Or, if you know of a news article about this bill to display here, email us the web address of this page and the web address of your suggested news article: Our editorial team will post relevant links as quickly as possible. Thanks for helping to build public knowledge about Congress.
Recent Blog Coverage
View All (28)
|
View Top Rated
H.R.2592: Safe Building Code Incentive Act of 2009 - U.S. Congress ...
... Wiki; News (1) & Blogs (45) · Videos (0) · Comments (0). This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it. .... OpenCongress is a
rtfa.net » Open for Questions: Response | Change.gov: The Obama ...
He was cosponsor of H.R. 2592, the Statesâ Rights to Medical Marijuana Act.[225][226] He opposes federal prohibition of this option in states such as California under Proposition 215. Paul has joined prominent liberal Democrats in ...
Bankruptcy Abuse Prevention and Consumer Protection Act of 2005 ...
H.R. 2592 (private trustee rights - Bill information on THOMAS): 10/01/1997 - Introduced by Rep. Goodlatte, R-VA (H.R. 2592 - Bill Text). 10/09/1997 - House Judiciary subcommittee hearing. 07/31/1998 - Reported, amended, by Hse Judi. ...

U.S. Congress - H.R.2592 Safe and Effective Drug Development Act of 2007



